重症血液病患者上呼吸道病毒检测的临床意义
该研究为前瞻性队列的事后分析,纳入17个ICU的747例重症血液病患者,ICU入院时鼻拭子行多重PCR检测。21.3%检出病毒,以鼻病毒/肠病毒(56.4%)和流感/副流感/呼吸道合胞病毒(30.7%)为主。病毒阳性与淋巴增殖性疾病、造血干细胞移植、激素或其他免疫抑制剂治疗、急性呼吸衰竭(25.5% vs 16.3%,P=0.004)及ICU死亡(28.9% vs 19.3%,P=0.008)相关。在急性呼吸衰竭患者中,任何呼吸道病毒检出与ICU死亡独立相关(OR 2.07,95%CI 1.22-3.50)。作者认为多重PCR可能有助于急性呼吸衰竭血液病患者的风险分层,但病毒是否对结局有因果作用尚需研究。
要点
- 重症血液病患者ICU入院时鼻拭子多重PCR病毒检出率21.3%,以鼻病毒/肠病毒(56.4%)和流感/副流感/呼吸道合胞病毒(30.7%)为主。
- 合并急性呼吸衰竭者病毒检出率高于无急性呼吸衰竭者(25.5% vs 16.3%,P=0.004)。
- 病毒阳性者ICU死亡率高于阴性者(28.9% vs 19.3%,P=0.008)。
- 在急性呼吸衰竭患者中,任何呼吸道病毒检出与ICU死亡独立相关(OR 2.07,95%CI 1.22-3.50)。
- 病毒检出与ICU死亡的关联对所有病毒均显著,以流感/副流感/呼吸道合胞病毒最强。
适用人群与场景
- 17个ICU收治的重症血液病患者,共747例,其中447例合并急性呼吸衰竭。
- ICU入院时采集鼻拭子并冻存,用于多重PCR检测。
研究设计与关键结果
- 研究类型为前瞻性队列的事后分析,纳入17个ICU的747例重症血液病患者(447例急性呼吸衰竭)。
- 21.3%的患者检出病毒,其中鼻病毒/肠病毒占56.4%,流感/副流感/呼吸道合胞病毒占30.7%。
- 总体ICU死亡率为26%,住院死亡率为37%。
- 病毒阳性与淋巴增殖性疾病、造血干细胞移植、激素或其他免疫抑制剂治疗、急性呼吸衰竭(25.5% vs 16.3%,P=0.004)及ICU死亡(28.9% vs 19.3%,P=0.008)相关。
- 在急性呼吸衰竭患者中,任何呼吸道病毒检出与ICU死亡独立相关(OR 2.07,95%CI 1.22-3.50)。
- 病毒检出与ICU死亡的关联对所有病毒均显著,以流感/副流感/呼吸道合胞病毒最强。
证据类型、等级与局限
- 证据类型:前瞻性队列研究的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为多重PCR检测可能有助于急性呼吸衰竭血液病患者的风险分层。
- 作者指出,需开展研究以明确呼吸道病毒是否对结局起因果作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Noninvasive diagnostic multiplex molecular tests may enable the early identification and treatment of viral infections in critically ill immunocompromised patients.
OBJECTIVES: To assess the association between viral detection in nasopharyngeal swabs and ICU mortality in critically ill hematology patients.
METHODS: This was a post hoc analysis of a prospective cohort of critically ill hematology patients admitted to 17 ICUs. Nasal swabs sampled and frozen at ICU admission were tested using a multiplex PCR assay. Predictors of ICU mortality and assay positivity were identified.
MEASUREMENTS AND MAIN RESULTS: Of the 747 patients (447 with acute respiratory failure [ARF]), 21.3% had a virus detected (56.4% rhinovirus/enterovirus and 30.7% influenza/parainfluenza/respiratory syncytial viruses). Overall ICU and hospital mortality rates were 26% and 37%, respectively. Assay positivity was associated with lymphoproliferative disorders, hematopoietic stem cell transplantation, treatment with steroids or other immunosuppressants, ARF (25.5% vs. 16.3%; P = 0.004), and death in the ICU (28.9% vs. 19.3%; P = 0.008). The association with ICU mortality was significant for all viruses and was strongest for influenza/parainfluenza/respiratory syncytial viruses. In patients with ARF, detection of any respiratory virus was independently associated with ICU mortality (odds ratio, 2.07; 95% confidence interval, 1.22-3.50).
CONCLUSIONS: Respiratory virus detection in the upper airway by multiplex PCR assay is common in critically ill hematology patients. In patients with ARF, respiratory virus detection was independently associated with ICU mortality. Multiplex PCR assay may prove helpful for the risk stratification of hematology patients with ARF. Studies to understand whether respiratory tract viruses play a causal role in outcomes are warranted.
参考来源
- Legoff J, Zucman N, Lemiale V, et al. Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients. Am J Respir Crit Care Med. 2019. PMID: 30230909. doi:10.1164/rccm.201804-0681OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。